Cytokinetics Incorporated (CYTK) is a clinical-stage biopharmaceutical company that focuses on developing therapies for people with debilitating diseases. With a strong pipeline and a commitment to innovation, the company aims to improve the lives of patients through the discovery and development of novel muscle activators and inhibitors.
Notification